Sign in

CIK 0001626878

  • Non-accelerated filer
  • Smaller reporting company

XBiotech Inc.

Sign in to watch
Ticker
XBIT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
Phone
+1 512-386-2900
Business address
5217 WINNEBAGO LANE, AUSTIN, TX, 78744
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale Chief Executive Officer sold 50,000 shares at an average $13.15 ($657,725)
  11. 4 Shares withheld for taxes Director gave up 213,493 shares (to pay taxes)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale Chief Executive Officer sold 89,286 shares at an average $12.67 ($1,131,099)
  15. 4 Open-market sale Chief Executive Officer sold 48,613 shares at an average $12.84 ($624,181)
  16. 4 Open-market sale Chief Executive Officer sold 60,901 shares at an average $13.34 ($812,117)
  17. 4 Open-market sale Chief Executive Officer sold 51,200 shares at an average $14.72 ($753,419)
  18. 4 Open-market sale Chief Executive Officer sold 50,000 shares at an average $15.15 ($757,584)
  19. 4 Open-market sale Chief Executive Officer sold 50,000 shares at $18.15 ($907,350)
  20. 4 Option exercise Director acquired 25,000 shares (option exercise)

Page 2 of 9 · 176 filings